Ecstasy and related compounds release neuroactive compounds including serotonin, dopamine

and noradrenaline as well as blocking neuronal re-uptake of these compounds. This leads to the elevated mood state as well as alterations in thermoregulation and autonomic dysfunction. This is also associated with enhanced release of arginine vasopressin, cortisol and adrenocorticotrophin.2 N-benzylpiperazine has gained popularity as a rave drug for producing sensation of euphoria, energy and desire to socialize and is not subject to the controlled drug restrictions that outlaw ecstasy.3 Seliciclib molecular weight While piperazine-based hallucinogens or stimulants are not currently used therapeutically, they are misused. Party pills containing BZP have many names on the market (e.g. A2, Nemesis, Frenzy, Charge Herbal, Black Pepper Extract, LBH589 research buy Herbal Ecstasy, Good Stuff, Legal X).4 BZP has been called a ‘natural’ product by some retailers, describing it as a ‘pepper extract’ or ‘herbal high’, when in fact the drug is entirely synthetic and has not been found to occur naturally. Piperazine derivatives were first synthesized in the 1950s as antihelminthic agents, but because of their lack of efficacy and significant side-effects they

were withdrawn from the market. In the 1970s and 1980s several studies showed that BZP had a stimulant, amphetamine-like effect, and in the 1990s the drug became popular for as recreational drug. In 2002, it was made illegal in USA and banned in most parts of Europe and Australia soon afterwards.5 In New Zealand, the sale of BZP and the other listed piperazines became illegal as of April 2008. The sale of BZP is legal in the UK and Canada and in general is sold as a legal alternative

to Ecstasy.1 The prevalence of party pill usage in the USA and the UK is increasing; exact numbers are unknown but in New Zealand in 2007 it was so widely used that an estimated 5 million pills were sold.6 Serious toxicity can occur even at a usual standard dose and are similar to methylenedioxymethamphetamine (MDMA, ‘ecstasy’) effects. In general, tablets and capsules contain 70–1000 mg BZP. Some products contain BZP in combination with TFMPP (3-Trifluoromethylphenylpiperazine) generally in a ratio of 2:1. An ingestion of 50–100 mg of BZP in an adult is unlikely to cause Mephenoxalone serious toxicity. Doses over 250 mg of a piperazine-based designer drug would be likely to cause moderate toxicity, such as anxiety, agitation, hypertension, tachycardia, palpitations, gastrointestinal upset and headache. Seizures, tremor, hallucinations, fever, chest pain and jaw clenching may accompany this. An increase of the dose to 500 mg can cause these effects to be prolonged and fatal.4,7 Apparent drug–drug synergism and adverse behavioural effects (e.g. seizures) are associated with high-dose administration of BZP especially in combination with TFMPP.